Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.59 | 1.55 |
NAV | ₹106.24 | ₹141.88 |
Fund Started | 11 Nov 2013 | 11 Feb 2008 |
Fund Size | ₹25975.38 Cr | ₹36827.67 Cr |
Exit Load | Exit load of 1% for investments beyond 10% if redeemed within 12 months | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.48% | 0.86% |
3 Year | 18.55% | 22.57% |
5 Year | 25.88% | 29.84% |
1 Year
3 Year
5 Year
Equity | 91.04% | 89.81% |
Cash | -1.87% | 10.19% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Krishna Institute of Medical Sciences Ltd | 2.87% |
CCL Products (India) Ltd. | 2.26% |
Kaynes Technology India Ltd. | 2.21% |
Brigade Enterprises Ltd. | 2.12% |
Cholamandalam Financial Holdings Ltd. | 2.08% |
Multi Commodity Exchange Of India Ltd. | 1.98% |
JB Chemicals & Pharmaceuticals Ltd. | 1.96% |
Blue Star Ltd. | 1.89% |
Nifty 50 | 1.86% |
City Union Bank Ltd. | 1.62% |
Name | Assets |
---|---|
Firstsource Solutions Ltd. | 4.90% |
Aster DM Healthcare Ltd. | 4.11% |
eClerx Services Ltd. | 4.02% |
Bank Of Baroda | 3.29% |
Gabriel India Ltd. | 3.17% |
Eris Lifesciences Ltd. | 2.73% |
Fortis Healthcare Ltd. | 2.65% |
Krishna Institute of Medical Sciences Ltd | 2.12% |
Sudarshan Chemical Industries Ltd. | 2.10% |
Indian Bank | 1.97% |
Name | Mayank Hyanki | Chirag Setalvad |
Start Date | 22 Nov 2024 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies. | The scheme seeks to provide long-term capital appreciation /income by investing predominantly in Small-Cap companies. |
Launch Date | 11 Nov 2013 | 11 Feb 2008 |
Description
Launch Date